Old Web
English
Sign In
Acemap
>
authorDetail
>
David J. Matye
David J. Matye
University of Oklahoma Health Sciences Center
Bile acid
Cholesterol 7 alpha-hydroxylase
FGF15
FGF19
PI3K/AKT/mTOR pathway
3
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental non-alcoholic steatohepatitis
2021
Cellular and molecular gastroenterology and hepatology
David J. Matye
Huaiwen Wang
Wenyi Luo
Rachel R. Sharp
Cheng Chen
Lijie Gu
Kenneth L. Jones
Wen-Xing Ding
Jacob E. Friedman
Tiangang Li
Show All
Source
Cite
Save
Citations (2)
Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice.
2021
Alcoholism: Clinical and Experimental Research
David J. Matye
Yuan Li
Cheng Chen
Xiaojuan Chao
Huaiwen Wang
Hong-Min Ni
Wen-Xing Ding
Tiangang Li
Show All
Source
Cite
Save
Citations (0)
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis.
2020
Nature Communications
Yifeng Wang
Sumedha Gunewardena
Feng Li
David J. Matye
Cheng Chen
Xiaojuan Chao
Taeyoon Jung
Yuxia Zhang
Maciej Czerwiński
Hong-Min Ni
Wen-Xing Ding
Tiangang Li
Show All
Source
Cite
Save
Citations (18)
1